ABSTRACT
Este estudo descreve um caso de Eritema Multiforme (EM) como a primeira manifestação clínica de Hanseníase (MH) em uma mulher de 35 anos. Quando atendida em um Hospital, a paciente apresentava febre, artralgia, e placas eritematosas em ambos os cotovelos e joelhos bilateralmente, algumas com bolhas e/ou necrose central. O diagnóstico foi confirmado por meio de biópsias de pele, que revelaram um padrão histopatológico compatível com EM, além da presença decélulas de Virchow e bacilos álcool-ácido resistentes (BAAR). Médicos em geral, especialmente os clínicos, devem considerar MH como diagnóstico diferencial de EM, especialmente em regiões endêmicas da doença.
This study describes a case of erythema multiforme (EM) as the first clinical manifestation of leprosy in a 35-year-old woman. She presented at the hospital with fever, arthralgia and erythematous plaques on both elbows and knees, some of them with bullous or necrotic center areas. The diagnosiswas confirmed by skin biopsy, which revealed a well-known EM pattern, and also showed the presence of Virchow cells and acid-fast bacilli. Physicians should be aware that leprosy must beconsidered in the differential diagnosis of EM, especially in endemic regions.
Subject(s)
Humans , Female , Adult , Erythema Multiforme , Leprosy/diagnosisABSTRACT
OBJECTIVES: We have recently found a high prevalence of non-typeable pneumococcal isolates (NTPn) circulating in day-care centers in Central Brazil, besides serotype 14 isolates. We therefore examined the genetic relationship among NTPn and serotype 14 from carriage and invasive pneumococcal isolates obtained from children attending emergency rooms enrolled in a population-based surveillance. METHODS: The isolates were characterized by Quellung reaction serotyping, PCR for the presence of pneumolysin and the loci for a capsule gene (cpsA) and the type 14 gene (cps14H) in all NTPn, and by multilocus sequence typing and pulsed field gel electrophoresis. RESULTS: 87.2% of the isolates were clustered into nine clusters. The major cluster included 41 pneumococcal serotype 14 (28 carriage and 13 invasive isolates) and two NTPn related to the global pneumococcal clone Spain(9V)-3. Overall, 95.4% of the NTPn carriage strains were genetically related to carriage or invasive strains expressing serotype 14. A dominant NTPn lineage was found, that grouped 14 pneumococcal strains. Almost half of the multidrug-resistant isolates grouped into the NTPn cluster. CONCLUSION: These findings provide baseline data to assess the impact of the pneumococcal vaccination on the molecular epidemiology of Streptococcus pneumoniae. Changes in frequency of NTPn isolates and also genetic changes should be carefully monitored post vaccination, to detect potential vaccine-escape or replacement disease by capsule switched strains, especially in areas where colonization with NTPn has been frequently observed.
Subject(s)
Bacterial Typing Techniques , Carrier State/epidemiology , Carrier State/microbiology , Pneumococcal Infections/epidemiology , Pneumococcal Infections/microbiology , Streptococcus pneumoniae/classification , Streptococcus pneumoniae/genetics , Bacterial Proteins/genetics , Brazil/epidemiology , Child, Preschool , DNA Fingerprinting , Electrophoresis, Gel, Pulsed-Field , Female , Genotype , Humans , Infant , Infant, Newborn , Male , Molecular Epidemiology , Pneumococcal Vaccines/immunology , Polymerase Chain Reaction , Prevalence , Sequence Analysis, DNA , Serotyping , Streptococcus pneumoniae/isolation & purification , Streptolysins/genetics , Virulence Factors/geneticsABSTRACT
A survey of nasopharyngeal carriage of penicillin nonsusceptible pneumococcal (PNSp) isolates was conducted among 1192 children attending 62 day care centers in Brazil, where pneumococcal vaccination has not been routinely introduced. Nasopharyngeal pneumococcal carriage was detected in 686 (57.6%) infants, and 178 (25.9%) of them carried PNSp isolates. Being less than 24 months of age, hospitalization in the previous 3 months, and recurrent acute otitis media were independently associated with PNSp. Serotypes 14, 23F, 19A, 6A, 6B and 19F were the most common serotype isolated accounting for 80% of the PNSp. A high proportion (35/332) of non-(sero)typeable isolates was detected, 62.9% of them PNSp. Serotypes coverage projected for the pneumococcal conjugate vaccine (PCV) 13-valent vaccine (72%) was significantly higher compared with PCV7 (58.4%) and PCV 10-valent vaccine (59.3%).
Subject(s)
Carrier State/microbiology , Nasopharynx/microbiology , Penicillin Resistance , Pneumococcal Infections/microbiology , Streptococcus pneumoniae/drug effects , Streptococcus pneumoniae/isolation & purification , Bacterial Typing Techniques , Brazil/epidemiology , Carrier State/epidemiology , Child Day Care Centers , Child, Preschool , Cross-Sectional Studies , Female , Hospitalization/statistics & numerical data , Humans , Infant , Male , Otitis Media/epidemiology , Pneumococcal Infections/epidemiology , Prevalence , Recurrence , Serotyping , Streptococcus pneumoniae/classificationABSTRACT
Data from a six-year follow-up of Trypanosoma cruzi-infected adolescents enrolled in a randomized, double-blind, clinical trial of benznidazole showed successful chemotherapy in 64.7% (95% confidence interval [CI] = 50.2-78.7) and 84.7% (95% CI = 66.8-92.9), respectively, by intention-to treat and by per protocol analysis measured by seronegativity in a chemiluminescent enzyme-linked immunosorbent assay with a purified trypomastigote mucin antigen. No incident case of cardiomyopathy was detected by electrocardiogram assessment in this cohort of adolescents who had been infected in childhood. The persistent and consistently long-term negative serologic reactions suggest the absence of the parasite in the treated patients and reinforces the recommendation of early benznidazole chemotherapy for T. cruzi-infected infants as a public health policy in endemic areas.
Subject(s)
Chagas Disease/drug therapy , Chagas Disease/immunology , Nitroimidazoles/administration & dosage , Trypanocidal Agents/administration & dosage , Trypanosoma cruzi/immunology , Adolescent , Adolescent Health Services , Adult , Animals , Antigens, Protozoan/analysis , Chagas Disease/blood , Double-Blind Method , Enzyme-Linked Immunosorbent Assay , Female , Follow-Up Studies , Humans , Male , Randomized Controlled Trials as Topic , Treatment OutcomeABSTRACT
OBJECTIVE: To assess the impact of the Haemophilus influenzae b (Hib) conjugate vaccine in reducing the incidence of meningitis among children under five years old. METHODS: A 'before-after' design was used to compare Hib meningitis incidence rates in the pre-vaccine (July 1995 - June 1999) and post-vaccine (July 1999 - June 2001) periods in the state of Goias, central Brazil. Bacterial meningitis case definition was based on World Health Organization criteria. Incidence rates of S. pneumoniae and N. meningitidis were used for comparison purposes. Chi-squared and Student's t tests were used for statistical analysis. P-values below 0.05 were considered as statistically significant. RESULTS: 979 children with acute bacterial meningitis were detected throughout the entire period. The incidence rate of Hib meningitis decreased from 10.8 (x10(5)) in the pre-vaccine period to 2.3 (x10(5)) in the 2nd year post vaccination, leading to a risk reduction of 78%, targeted to the 7-23 months age group (p<0.05). A total of 65 cases of Hib meningitis were prevented. An increase in S. pneumoniae meningitis was observed. Vaccine failure was detected in one child. CONCLUSIONS: This study showed that mass immunization with Hib conjugate vaccine brought about an expressive decline in childhood Hib meningitis in Goias soon after the first year. Notwithstanding, an enhancement of surveillance using high-accuracy tools is essential to: (i) detect a possible reemergence of Hib; (ii) identify vaccine failure, and (iii) monitor changes in the H. influenzae serotype profile over time.
Subject(s)
Haemophilus Vaccines/administration & dosage , Haemophilus influenzae type b/immunology , Meningitis, Haemophilus/epidemiology , Tetanus Toxoid/administration & dosage , Brazil/epidemiology , Child, Preschool , Female , Humans , Incidence , Infant , Male , Meningitis, Haemophilus/prevention & control , Vaccines, Conjugate/administration & dosageABSTRACT
OBJETIVO: Avaliar o impacto da vacinação contra o Haemophilus influenzae b na incidência de meningites em crianças menores de cinco anos de idade. MÉTODOS: Utilizou-se o delineamento tipo "antes-depois" para comparar as taxas de incidência de meningites por Haemophilus influenzae b nos períodos pré-vacinação (julho/95-junho/99) e pós-vacinação (julho/99-junho/2001) no Estado de Goiás. A definição de caso de meningite bacteriana seguiu os critérios da Organização Mundial de Saúde. As taxas de meningite por Streptococcus pneumoniae e Neisseria. meningitidis foram utilizadas para efeito de comparação. Para análise estatística foram utilizados o teste de chi2 e o t de Student. Valores de p<0,05 foram considerados estatisticamente significantes. RESULTADOS: Foi detectada meningite bacteriana aguda em 979 crianças no período de estudo. A incidência de meningite por Haemophilus influenzae b diminuiu de 10,8x10(5) no período pré-vacinal para 2,3x10(5) no segundo ano pós-vacina, significando 78 por cento de redução no risco, principalmente na faixa etária de 7-23 meses (p<0,05). Foram prevenidos 65 casos de meningite por Haemophilus influenzae b. Observou-se aumento na incidência de meningite por S. pneumoniae. Foi observada falha vacinal em um caso. CONCLUSÕES: Expressivo declínio da incidência de meningite por Haemophilus influenzae b foi detectado, precocemente, logo após o primeiro ano de introdução da vacina contra o Haemophilus influenzae b. Assim, se faz necessária a vigilância contínua com instrumental de alta acurácia para: (i) detectar re-emergência do Haemophilus influenzae b; (ii) avaliar possibilidade de falha vacinal; (iii) identificar mudanças no padrão dos sorotipos do H. influenzae.
Subject(s)
Effectiveness , Haemophilus influenzae type b , Meningitis, Haemophilus/prevention & control , Haemophilus VaccinesABSTRACT
Em uma populaçäo constituída quase que exclusivamente por empregados de uma olaria e seus familiares, no município de Edeia, Estado de Goiás, Brasil, foi pesquisada a taxa de portador de meningococo na nasofaringe, após a ocorrência de dois casos de doença meningocócica. De uma amostra original de 165 indivíduos pertencentes a 47 famílias, foram estudados 133. A Neisseria meningitidis foi isolada em 57 (42,9%) indivíduos do grupo estudado, havendo predomínio do sorogrupo B com 87,7%, em relaçäo ao sorogrupo A, cuja taxa foi 12,3%. Surpreendentemente, a faixa etária de 0 a 15 anos apresentou a maior taxa, 75,4%, e a de maiores de 30 anos ficou com a menor taxa, 8,8%, diferença esta altamente significante. O percentual para o sexo feminino foi de 59,6% e para o sexo masculino 40,4%, näo havendo diferença significativa quanto ao sexo. Os resultados obtidos neste estudo nos permitiram conhecer a taxa de portadores e o sorogrupo predominante e sonseqüente profilaxia adequada na eventualidade de ocorrência de doença naquela comunidade, na qual, durante um ano, näo se registraram novos casos de doença meningocócica
